Ignite Creation Date:
2024-10-25 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06651294
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-18
Brief Title:
Efficacy of Neorenal Forte for the Complete Elimination of Residual Fragments
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Efficacy and Safety of Neorenal Forte as Adjuvant Treatment for the Complete Elimination of Residual Fragments After Flexible Ureterorenoscopy With Laser Lithotripsy for Renal Calculi
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NERFA
Brief Summary:
The purpose of this study is to evaluate the efficacy of a specialized formula of phytotherapeutic extracts Neorenal Forte aiding the complete elimination of residual fragments after fURS in adults
Detailed Description:
The study is being initiated to support the informed decision making by healthcare specialists on the initiation of a specific and safe formula of phytotherapeutic extracts with duration at least three months after endourological procedures as a routine part of urolithiasis treatment aiding the complete elimination of residual fragments which will allow minimizing of the short-term and long-term complications
By evaluating the percentage of complete elimination of residual fragments or fragments 2 mm in diameter we aim to estimat the efficacy and safety of Neorenal Forte
By evaluating the percentage of complete elimination of residual fragments or fragments 2 mm in diameter we aim to estimat the efficacy and safety of Neorenal Forte
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None